Benign lesion number | Histopathology | L/B ratio | Assessment | ||
---|---|---|---|---|---|
99mTc sestamibi | 99mTc maraciclatide | 99mTc sestamibi | 99mTc maraciclatide | ||
1 | ADH | 1.24 | 1.28 | 3 | 3 |
2 | ADHa | Not seen | 1.34 | 1 | 4 |
3 | Benign fibrocystic changes | Not seen | Not seen | 1 | 2 |
4 | Benign fibrocystic changes | Not seen | Not seen | 1 | 1 |
5 | Benign fibrocystic changes | Not seen | Not seen | 1 | 2 |
6 | Benign fibrocystic changes | Not seen | Not seen | 1 | 1 |
7 | Benign fibrocystic changes | Not seen | Not seen | 1 | 2 |
8 | Benign fibrocystic changes | Not seen | Not seen | 1 | 1 |
9 | Fibroadenoma | 1.52 | 1.35 | 3 | 3 |
10 | Fibroadenoma | Not seen | Not seen | 1 | 2 |
11 | Fibroadenoma | Not seen | Not seen | 1 | 1 |
12 | Fibroadenoma | Not seen | Not seen | 1 | 2 |
13 | Fibroadenoma | 1.24 | 1.13 | 3 | 4 |
14 | Fibroadenoma | 1.14 | 1.25 | 2 | 3 |
15 | Fibroadenomab | 1.12 | 1.11 | 4 | 4 |
16 | Inflammatory tissue | 1.25 | 1.36 | 4 | 4 |
17 | Intramammary lymph node | 1.14 | Not seen | 4 | 2 |
18 | Papilloma | Not seen | Not seen | 2 | 2 |
19 | Papilloma | 1.07 | 1.13 | 2 | 2 |
20 | PASH | 2.35 | 2.76 | 2 | 2 |